Specifications

• Conjugation:
  Biotin
• Protein/Peptide Type:
  Recombinant
• Source:
  HEK293 cells
• Species:
  Human
• Storage Conditions:
  –20 °C
• Endotoxin Content:
  Less than 1.0 EU per μg by the LAL method.
• Biological Activity:
  Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.; Measured by its binding ability in a functional ELISA. Immobilized human VEGFR1/R2, Fc tag at 2μg/mL (100 μL/well) can bind Biotinylated Human VEGF (Cat. No. VE5-H8210) with a linear range of 0.39-3.1 ng/mL (QC tested).; Measured by its binding ability in a functional ELISA. Immobilized Human Neuropilin-1, His Tag (Cat.No. NR1-H5228) at 2 μg/mL (100 μL/well) can bind Biotinylated Human VEGF165 (Cat.No. VE5-H8210) with a linear range of 5-40 ng/mL (Routinely tested).; Measured by its binding ability in a functional ELISA. Immobilized Anti-VEGF MAb,Human IgG1 (Avastin) at 5μg/mL (100 μL/well) can bind Biotinylated Human VEGF165 (Cat. No. VE5-H8210) with a linear range of 0.24-1.95 ng/mL (Routinely tested).
• Protease-free:
  Y
• Animal-Free:
  Y
• Protein Synonyms:
  RP1-261G23.1|MVCD1|MGC70609|VEGFA|VPF
• UniProtKB:
  P15692
• Protein/Peptide Name:
  VEGF165
• Purity:
  >95% as determined by reduced SDS-PAGE.
• Molecular Weight:
  19 kDa (monomer)
• Endotoxin Level:
  Low
• Formulation:
  Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.
• Shipping Temperature:
  Powder,RT